Integra Lifesciences Holdings Corp [IART] Insider DAVIS ROBERT T. JR. sells 8,348 Shares – Latest News

Integra Lifesciences Holdings Corp’s recent filing unveils that its EVP & President, TT DAVIS ROBERT T. JR. unloaded Company’s shares for reported $0.31 million on Mar 06 ’24. In the deal valued at $36.59 per share,8,348 shares were sold. As a result of this transaction, DAVIS ROBERT T. JR. now holds 49,893 shares worth roughly $1.67 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Mosebrook Jeffrey sold 1,177 shares, generating $52,329 in total proceeds. Upon selling the shares at $44.46, the SVP, Fin & PAO now owns 23,458 shares.

Before that, De Witte Jan bought 7,792 shares. Integra Lifesciences Holdings Corp shares valued at $299,986 were divested by the President & CEO at a price of $38.50 per share. As a result of the transaction, De Witte Jan now holds 12,798 shares, worth roughly $0.43 million.

Wells Fargo upgraded its Integra Lifesciences Holdings Corp [IART] rating to an Overweight from a an Equal weight in a research note published on December 05, 2023; the price target was increased to $49 from $40. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in mid November with a ‘”a Buy”‘ rating. Morgan Stanley also remained covering IART and has decreased its forecast on August 24, 2023 with a “an Underweight” recommendation from previously “an Equal-weight” rating. Jefferies revised its rating on July 12, 2023. It rated IART as “a Buy” which previously was an “a Hold”.

Price Performance Review of IART

On Tuesday, Integra Lifesciences Holdings Corp [NASDAQ:IART] saw its stock fall -3.46% to $33.52. Over the last five days, the stock has gained 0.36%. Integra Lifesciences Holdings Corp shares have fallen nearly -23.03% since the year began. Nevertheless, the stocks have fallen -40.69% over the past one year. While a 52-week high of $59.33 was reached on 02/20/24, a 52-week low of $33.24 was recorded on 03/25/24. SMA at 50 days reached $39.10, while 200 days put it at $40.43. A total of 0.51 million shares were traded, compared to the trading of 0.82 million shares in the previous session.

Levels Of Support And Resistance For IART Stock

The 24-hour chart illustrates a support level at 33.14, which if violated will result in even more drops to 32.75. On the upside, there is a resistance level at 34.27. A further resistance level may holdings at 35.01. The Relative Strength Index (RSI) on the 14-day chart is 33.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.24%. Stochastics %K at 39.01% indicates the stock is a holding.

How much short interest is there in Integra Lifesciences Holdings Corp?

A steep rise in short interest was recorded in Integra Lifesciences Holdings Corp stocks on Mar 15, 2024, dropping by -0.28 million shares to a total of 2.21 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 2.49 million shares. There was a decline of -12.67%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 3.27% of the overall stock float, the days-to-cover ratio (short ratio) fell to 2.55.

Most Popular